Immunovant IMVT
NASDAQ IMVT
$33.62 -0.03 (-0.09%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immunovant (IMVT) Interest & Investment Income (2019)

Updated

Immunovant (IMVT) recorded Interest & Investment Income of $1.02 million in fiscal Q2 2020 (quarter ended Sep 30, 2019), up 200.0% from the prior quarter.

Analysis

Immunovant (IMVT) Interest & Investment Income (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Immunovant 6.93 Bn 6.93 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 683,140.00
Jun 30, 2019 341,558.00
API Access

Immunovant Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=IMVT&period=max&api_key=YOUR_API_KEY